Mammalian Cell Fermentation Technology Market Share

North American Market Forecasts

The North America mammalian cell fermentation technology market is predicted to capture the largest share of about 35% over the forecast period. This growth of the market in this region is poised to be dominated by rising investment in biotechnology. For instance, in order to increase the use of biomanufacturing for antibiotics, active pharmaceutical ingredients (APIs), and other critical starting materials required to make life-saving drugs and combat pandemics, the Department of Health and Human Services will invest over USD 39 million. Furthermore, there are number of various key biopharmaceutical companies in this region focusing in the field of mammalian cell hence boosting the market growth. 

APAC Market Analysis

The mammalian cell fermentation technology market in Asia Pacific is predicted to have notable growth over the forecast period. The major factor to influence the market expansion is growth in patient traveling for medical treatment in this region. This is since, Asian nations are frequently chosen as medical tourism destinations because of how reasonably priced their medical services are. Numerous variables, including reduced living expenses, decreased operating costs in healthcare facilities, and favorable foreign exchange rates, are responsible for this affordability. Therefore, the market for mammalian cell fermentation is projected to grow in this region.